The Manufacturers Life Insurance Company Has $802,000 Stock Holdings in Trupanion, Inc. (NASDAQ:TRUP)

The Manufacturers Life Insurance Company boosted its stake in shares of Trupanion, Inc. (NASDAQ:TRUP) by 6.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 16,637 shares of the financial services provider’s stock after purchasing an additional 962 shares during the period. The Manufacturers Life Insurance Company’s holdings in Trupanion were worth $802,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the stock. Jones Financial Companies Lllp boosted its position in Trupanion by 71.7% during the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 238 shares during the last quarter. Coppell Advisory Solutions LLC boosted its position in Trupanion by 58.3% during the fourth quarter. Coppell Advisory Solutions LLC now owns 1,249 shares of the financial services provider’s stock valued at $61,000 after purchasing an additional 460 shares during the last quarter. SBI Securities Co. Ltd. acquired a new position in Trupanion during the fourth quarter valued at approximately $25,000. Swiss National Bank boosted its position in Trupanion by 1.1% during the fourth quarter. Swiss National Bank now owns 66,310 shares of the financial services provider’s stock valued at $3,196,000 after purchasing an additional 700 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its position in Trupanion by 2.7% during the third quarter. JPMorgan Chase & Co. now owns 28,317 shares of the financial services provider’s stock valued at $1,189,000 after purchasing an additional 738 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on TRUP. Lake Street Capital reduced their price target on Trupanion from $65.00 to $60.00 and set a “buy” rating for the company in a research report on Friday, May 2nd. Piper Sandler dropped their price objective on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th. Finally, Stifel Nicolaus dropped their price objective on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Trupanion presently has a consensus rating of “Moderate Buy” and an average target price of $51.80.

Trupanion Price Performance

NASDAQ:TRUP opened at $45.73 on Thursday. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The stock’s 50 day moving average price is $37.43 and its two-hundred day moving average price is $44.45. The firm has a market capitalization of $1.96 billion, a price-to-earnings ratio of -198.83, a P/E/G ratio of 6.02 and a beta of 1.72. Trupanion, Inc. has a 12-month low of $25.90 and a 12-month high of $57.90.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.02. The company had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The firm’s quarterly revenue was up 11.7% compared to the same quarter last year. During the same quarter last year, the company earned ($0.16) earnings per share. On average, analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Insider Transactions at Trupanion

In other news, CEO Margaret Tooth sold 2,294 shares of the stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the transaction, the chief executive officer now owns 118,784 shares in the company, valued at approximately $3,728,629.76. This trade represents a 1.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Emily Dreyer sold 14,025 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $32.41, for a total value of $454,550.25. Following the transaction, the senior vice president now owns 27,645 shares in the company, valued at approximately $895,974.45. This trade represents a 33.66% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,792 shares of company stock worth $1,122,802. Company insiders own 5.50% of the company’s stock.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.